Clinical trial

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

NCT04541290

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-09-22

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2020-09-22Date precision: day

Registry last updated2022-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Lymphedemaunresolved

Interventions

Protopic 0.1 % Topical OintmentDRUG

Sponsors & collaborators

Odense University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04541290 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.